SG Americas Securities’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-414,874
| Closed | -$42.1M | – | 3378 |
|
|
2025
Q4 | $42.1M | Buy |
414,874
+384,628
| +1,272% | +$30.9M | 0.05% | 260 |
|
|
2025
Q3 | $1.66M | Buy |
30,246
+14,083
| +87% | +$704K | 0.01% | 1056 |
|
|
2025
Q2 | $859K | Buy |
16,163
+514
| +3% | +$26.1K | ﹤0.01% | 1276 |
|
|
2025
Q1 | $677K | Buy |
+15,649
| New | +$792K | ﹤0.01% | 1523 |
|
|
2024
Q4 | – | Sell |
-6,916
| Closed | -$471K | – | 3278 |
|
|
2024
Q3 | $471K | Buy |
6,916
+2,496
| +56% | +$141K | ﹤0.01% | 1737 |
|
|
2024
Q2 | $187K | Sell |
4,420
-9,592
| -68% | -$528K | ﹤0.01% | 2201 |
|
|
2024
Q1 | $968K | Buy |
+14,012
| New | +$886K | ﹤0.01% | 1149 |
|
|
2023
Q4 | – | Sell |
-8,723
| Closed | -$595K | – | 3205 |
|
|
2023
Q3 | $595K | Sell |
8,723
-1,370
| -14% | -$116K | 0.01% | 1636 |
|
|
2023
Q2 | $948K | Buy |
10,093
+6,273
| +164% | +$489K | 0.01% | 1081 |
|
|
2023
Q1 | $259K | Sell |
3,820
-10,303
| -73% | -$662K | ﹤0.01% | 2223 |
|
|
2022
Q4 | $699K | Buy |
+14,123
| New | +$577K | 0.01% | 1242 |
|
|
2022
Q3 | – | Sell |
-77,107
| Closed | -$3.04M | – | 3290 |
|
|
2022
Q2 | $3.04M | Sell |
77,107
-37,708
| -33% | -$2.02M | 0.03% | 521 |
|
|
2022
Q1 | $8.03M | Buy |
114,815
+112,052
| +4,055% | +$8.19M | 0.06% | 267 |
|
|
2021
Q4 | $215K | Sell |
2,763
-6,432
| -70% | -$568K | ﹤0.01% | 2633 |
|
|
2021
Q3 | $878K | Sell |
9,195
-58,527
| -86% | -$6.18M | ﹤0.01% | 2017 |
|
|
2021
Q2 | $8.42M | Buy |
67,722
+66,576
| +5,809% | +$7.95M | 0.04% | 412 |
|
|
2021
Q1 | $151K | Sell |
1,146
-2,594
| -69% | -$355K | ﹤0.01% | 2851 |
|
|
2020
Q4 | $496K | Sell |
3,740
-4,222
| -53% | -$511K | ﹤0.01% | 1997 |
|
|
2020
Q3 | $812K | Buy |
7,962
+183
| +2% | +$15.8K | 0.01% | 1320 |
|
|
2020
Q2 | $676K | Sell |
7,779
-10,465
| -57% | -$836K | 0.01% | 1797 |
|
|
2020
Q1 | $1.06M | Buy |
18,244
+11,721
| +180% | +$952K | 0.01% | 1247 |
|
|
2019
Q4 | $603K | Sell |
6,523
-19,568
| -75% | -$1.72M | 0.01% | 1617 |
|
|
2019
Q3 | $2.36M | Buy |
26,091
+3,995
| +18% | +$455K | 0.02% | 854 |
|
|
2019
Q2 | $2.61M | Buy |
22,096
+17,355
| +366% | +$1.75M | 0.02% | 856 |
|
|
2019
Q1 | $411K | Buy |
4,741
+2,207
| +87% | +$188K | ﹤0.01% | 2001 |
|
|
2018
Q4 | $160K | Sell |
2,534
-14,116
| -85% | -$969K | ﹤0.01% | 2496 |
|
|
2018
Q3 | $1.31M | Sell |
16,650
-116,076
| -87% | -$7.57M | 0.01% | 1485 |
|
|
2018
Q2 | $7.94M | Buy |
132,726
+106,147
| +399% | +$5.71M | 0.07% | 283 |
|
|
2018
Q1 | $1.07M | Buy |
+26,579
| New | +$1.3M | 0.01% | 1295 |
|
|
2017
Q4 | – | Sell |
-3,886
| Closed | -$183K | – | 3321 |
|
|
2017
Q3 | $183K | Buy |
+3,886
| New | +$156K | ﹤0.01% | 2656 |
|
|
2017
Q1 | – | Sell |
-21,372
| Closed | -$286K | – | 3353 |
|
|
2016
Q4 | $286K | Sell |
21,372
-2,203
| -9% | -$35.6K | ﹤0.01% | 2072 |
|
|
2016
Q3 | $438K | Buy |
+23,575
| New | +$415K | ﹤0.01% | 1821 |
|
|
2015
Q4 | – | Sell |
-12,957
| Closed | -$233K | – | 2775 |
|
|
2015
Q3 | $233K | Buy |
12,957
+8,195
| +172% | +$188K | ﹤0.01% | 1358 |
|
|
2015
Q2 | $142K | Sell |
4,762
-2,997
| -39% | -$75.3K | ﹤0.01% | 2165 |
|
|
2015
Q1 | $171K | Sell |
7,759
-7,692
| -50% | -$195K | ﹤0.01% | 1968 |
|
|
2014
Q4 | $424K | Buy |
15,451
+1,327
| +9% | +$32.3K | ﹤0.01% | 1767 |
|
|
2014
Q3 | $274K | Sell |
14,124
-18,595
| -57% | -$341K | ﹤0.01% | 1817 |
|
|
2014
Q2 | $557K | Buy |
32,719
+23,307
| +248% | +$321K | ﹤0.01% | 1632 |
|
|
2014
Q1 | $133K | Buy |
+9,412
| New | +$127K | ﹤0.01% | 2102 |
|
|
2013
Q4 | – | Sell |
-18,313
| Closed | -$216K | – | 2736 |
|
|
2013
Q3 | $216K | Buy |
+18,313
| New | +$235K | ﹤0.01% | 2131 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
SG Americas Securities's EXAS Position: Q1 2026 in Review
SG Americas Securities sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 414,874 shares — an estimated $42.1M sold.
SG Americas Securities first reported a position in EXAS in Q3 2013 and held it in 40 quarters. The position peaked at $42.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- SG Americas Securities reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- SG Americas Securities sold 414,874 Exact Sciences shares in Q1 2026, an estimated $42.1M.
- SG Americas Securities first reported a position in Exact Sciences in Q3 2013 and held it in 40 quarters.
- SG Americas Securities's Exact Sciences position peaked at $42.1M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.